Cytokinetics Incorporated (CYTK) Fell -5.46% or -0.5 To Price $8.65 On Monday


Cytokinetics Incorporated (CYTK) fell -5.46% or -0.5 to $8.65. It is near to 205225 shares traded, which is 78.09% compare to the average total volume 262814. The market cap of CYTK is $468.81 million. The year to date change is 4.57%. The 52 week price range is from $6.75 to $15.95. Price of CYTK have changed -2.14% during last week. It have changed 27.08% over last month, 19.61% over last 3 months, 10.91% over last 6 months and -35.79% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 8.09. It is -6.47% below current price. The 200-day Moving Averages for CYTK is 10.42. It is 20.46% above current price. The 52-week High is 15.95. It is 84.39% from the current price. The 52-week Low is 6.75. It is -21.97% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CYTK is 10.6 on 2018-04-30. Short % to float is 5.57%. There are some statistics of CYTK. It is has market cap $468.81 million. The share outstanding is 54.20 million. The average volume is 262814. The revenue is 9.22M. It has 888.51M cash and 60.46M in debt. The percent of top 15 Institution holding is 75.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -125.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -45.04%.


Tags:

Share this post